These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34396510)

  • 1. Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.
    Henry A; Bracquemart C; Naguib D; Chantepie S; Cheze S; Johnson-Ansah HA
    Br J Haematol; 2021 Nov; 195(3):469-471. PubMed ID: 34396510
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib.
    Janjetovic S; Asemissen AM; Dicker F; Binder M; Dierlamm J; Bokemeyer C; Schafhausen P
    Tumori; 2019 Dec; 105(6):NP8-NP11. PubMed ID: 30935343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
    Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
    Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.
    Krysiak K; Christopher MJ; Skidmore ZL; Demeter RT; Magrini V; Kunisaki J; O'Laughlin M; Duncavage EJ; Miller CA; Ozenberger BA; Griffith M; Wartman LD; Griffith OL
    Blood Cancer J; 2016 Apr; 6(4):e413. PubMed ID: 27058228
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.
    Nakamura F; Arai H; Nannya Y; Ichikawa M; Furuichi S; Nagasawa F; Takahashi W; Handa T; Nakamura Y; Tanaka H; Nakamura Y; Sasaki K; Miyano S; Ogawa S; Mitani K
    Int J Hematol; 2021 Jun; 113(6):936-940. PubMed ID: 33400143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report.
    Oñate G; Blanco ML; Pratcorona M
    Med Clin (Barc); 2019 May; 152(10):419-420. PubMed ID: 30392698
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation.
    Gotoh M; Tauchi T; Yoshizawa S; Kitahara T; Kiguchi T; Kimura Y; Ohyashiki K
    Int J Hematol; 2010 Jan; 91(1):128-31. PubMed ID: 20047099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institution.
    Young PE; Kanagal-Shamanna R; Hu S; Tang G; Thakral B; Daver N; Issa GC; Medeiros LJ; Konoplev S
    Leuk Res; 2021 Dec; 111():106685. PubMed ID: 34438119
    [No Abstract]   [Full Text] [Related]  

  • 12. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
    Chen Z; Shao C; Wang W; Zuo Z; Mou X; Hu SJ; DiGiuseppe JA; Zu Y; Medeiros LJ; Hu S
    Leukemia; 2017 Mar; 31(3):585-592. PubMed ID: 27560111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
    Shah NP; Bhatia R; Altman JK; Amaya M; Begna KH; Berman E; Chan O; Clements J; Collins RH; Curtin PT; DeAngelo DJ; Drazer M; Maness L; Metheny L; Mohan S; Moore JO; Oehler V; Pratz K; Pusic I; Rose MG; Shomali W; Smith BD; Styler M; Talpaz M; Tanaka TN; Tantravahi S; Thompson J; Tsai S; Vaughn J; Welborn J; Yang DT; Sundar H; Gregory K
    J Natl Compr Canc Netw; 2024 Feb; 22(1):43-69. PubMed ID: 38394770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.
    Miyashita N; Onozawa M; Suto K; Fujisawa S; Okazaki N; Hidaka D; Ohigashi H; Yasumoto A; Sugita J; Hashimoto D; Matsuno Y; Teshima T
    Intern Med; 2022 Apr; 61(7):1049-1054. PubMed ID: 34511573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML.
    Asemissen AM; Dierlamm J
    Blood; 2017 Sep; 130(10):1274. PubMed ID: 28882836
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
    Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
    Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    Kolenova A; Maloney KW; Hunger SP
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.
    Zagaria A; Anelli L; Coccaro N; Tota G; Casieri P; Cellamare A; Impera L; Brunetti C; Minervini A; Minervini CF; Delia M; Cumbo C; Orsini P; Specchia G; Albano F
    Virchows Arch; 2015 Sep; 467(3):357-63. PubMed ID: 26149409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.